In the BioHarmony Drug Report Database

"Preview" Icon

Pioglitazone

Actos, Glustin (pioglitazone) is a small molecule pharmaceutical. Pioglitazone was first approved as Actos on 1999-07-15. It is used to treat type 2 diabetes mellitus in the USA. It has been approved in Europe to treat type 2 diabetes mellitus. The pharmaceutical is active against peroxisome proliferator-activated receptor gamma. In addition, it is known to target transient receptor potential cation channel subfamily M member 3.

 

Trade Name

 

Actos, Glustin
 

Common Name

 

pioglitazone
 

ChEMBL ID

 

CHEMBL595
 

Indication

 

type 2 diabetes mellitus
 

Drug Class

 

Ppst agonists (thiazolidene derivatives)

Image (chem structure or protein)

Pioglitazone structure rendering